OSL oncosil medical ltd

Albert EI agree. A couple of points to be made:-(1) FDA will...

  1. 2,588 Posts.
    lightbulb Created with Sketch. 257
    Albert E

    I agree. A couple of points to be made:-

    (1) FDA will most likely not even require 300 patient study. It may well be significantly smaller.

    (2) BSI clearly asked the company for a 20 patient supplementary data to complement the existing data set back in 2016.

    (3) The company supplied not only 20 patient data but over 40 which showed excellent safety profile and a clinical benefit.

    (4) The naysayers here have an ulterior motive.

    Cheers

    GW



 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.02
Change
0.020(2.00%)
Mkt cap ! $14.50M
Open High Low Value Volume
$1.00 $1.04 99.5¢ $44.55K 44.45K

Buyers (Bids)

No. Vol. Price($)
1 192 $1.03
 

Sellers (Offers)

Price($) Vol. No.
$1.04 6234 1
View Market Depth
Last trade - 15.48pm 25/06/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.